Obesity and Diabetes Therapy
New obesity and diabetes therapy findings from Eastern Virginia Medical School, Department of Internal Medicine described
Published in Obesity and Diabetes Week, March 22nd, 2010
Data detailed in 'Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice' have been presented. "Obesity, hypertension, cardiovascular disease, and inflammation are closely associated with the rising incidence of diabetes mellitus. One pharmacological target that may have significant potential to lower the risk of obesity-related diseases is the angiotensin type 1 receptor (AT1R)," scientists writing in the journal Hypertension report.
"We examined the hypothesis that the AT1R blocker valsartan reduces the metabolic consequences and inflammatory effects of a high-fat (Western) diet in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Elsevier Health Sciences
Farm-to-school programs motivate school food service professionals - Journal of the National Cancer Institute
High weight associated with risk of colorectal tumors without microsatellite instability - UT Southwestern Medical Center
Gastric bypass surgery increases risk of kidney stones - Angiogenesis
Investigators at University of Colorado, Medical Department target angiogenesis - Anovulation
Data on anovulation detailed by researchers at University of Michigan - Atrial Fibrillation
Investigators at Malmo University zero in on atrial fibrillation - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
